SPI.L Stock Analysis
SP
Avoid
Based on Eyestock quantitative analysis, SPI.L`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Market cap $B
1.258
Dividend yield
0.98 %
Shares outstanding
404.08 B
Spire Healthcare Group Plc operates as a private hospital group, which offers diagnostics, in-patient daycase and out-patient care procedures in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery and also diagnostic services including imaging and pathology, as well as out-patient services, such as consulting, minor procedures, treatments, health checks and physiotherapy. The firm offer a range of treatments and services, such as Bones and joints, Cosmetic surgery, Eye surgery and treatments, Heart treatments, Men's health, Urology, Weight loss, Women's health, Back surgery, Breast enlargement, Cataract removal surgery, Gastric bypass surgery, Hip replacement surgery, Knee replacement, Prostate surgery, Cardiac computerized tomography (CT) scan, CT scan, Magnetic resonance imaging (MRI) scan, Ultrasound scan, X-ray, Bupa health and wellbeing plans, Spire General Practitioner (GP), Conditions and symptoms, Cataracts, Foot pain, Hip pain, Knee pain, Osteoarthritis, Rheumatoid arthritis, Sciatica and Spinal stenosis. The company also provides wellness online tools and communities, Healthy lifestyle digital content, Virtual triage, eBooking services, Digital GP, ePrescribing, Direct to consumer testing, Chronic Disease Management and Digital care at home.